142 related articles for article (PubMed ID: 18974023)
1. Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.
Nobumoto A; Oomizu S; Arikawa T; Katoh S; Nagahara K; Miyake M; Nishi N; Takeshita K; Niki T; Yamauchi A; Hirashima M
Clin Immunol; 2009 Mar; 130(3):322-30. PubMed ID: 18974023
[TBL] [Abstract][Full Text] [Related]
2. Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation.
Arikawa T; Saita N; Oomizu S; Ueno M; Matsukawa A; Katoh S; Kojima K; Nagahara K; Miyake M; Yamauchi A; Kohrogi H; Hirashima M
Eur J Immunol; 2010 Feb; 40(2):548-58. PubMed ID: 19902429
[TBL] [Abstract][Full Text] [Related]
3. Galectin-9 attenuates acute lung injury by expanding CD14- plasmacytoid dendritic cell-like macrophages.
Kojima K; Arikawa T; Saita N; Goto E; Tsumura S; Tanaka R; Masunaga A; Niki T; Oomizu S; Hirashima M; Kohrogi H
Am J Respir Crit Care Med; 2011 Aug; 184(3):328-39. PubMed ID: 21562126
[TBL] [Abstract][Full Text] [Related]
4. Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages.
Kadowaki T; Arikawa T; Shinonaga R; Oomizu S; Inagawa H; Soma G; Niki T; Hirashima M
Clin Immunol; 2012 Mar; 142(3):296-307. PubMed ID: 22177847
[TBL] [Abstract][Full Text] [Related]
5. NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin.
Cao MY; Lee Y; Feng N; Li H; Du C; Miao D; Li J; Lee V; Jin H; Wang M; Gu X; Wright JA; Young AH
Cancer Immunol Immunother; 2005 Mar; 54(3):229-42. PubMed ID: 15378281
[TBL] [Abstract][Full Text] [Related]
6. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
7. Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages.
Li H; Cao MY; Lee Y; Lee V; Feng N; Benatar T; Jin H; Wang M; Der S; Wright JA; Young AH
Cancer Immunol Immunother; 2005 Nov; 54(11):1115-26. PubMed ID: 15891881
[TBL] [Abstract][Full Text] [Related]
8. Regulation of natural killer cell activation: implementation for the control of tumor metastasis.
Hanna N
Nat Immun Cell Growth Regul; 1983-1984; 3(1):22-33. PubMed ID: 6235447
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice.
Akao Y; Ebihara T; Masuda H; Saeki Y; Akazawa T; Hazeki K; Hazeki O; Matsumoto M; Seya T
Cancer Sci; 2009 Aug; 100(8):1494-501. PubMed ID: 19432881
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo.
Persson CM; Chambers BJ
Eur J Immunol; 2010 Aug; 40(8):2155-64. PubMed ID: 20540112
[TBL] [Abstract][Full Text] [Related]
11. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.
Jiang Q; Wei H; Tian Z
J Immunother; 2008; 31(6):555-62. PubMed ID: 18528299
[TBL] [Abstract][Full Text] [Related]
12. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
13. Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells.
Capobianco A; Manfredi AA; Monno A; Rovere-Querini P; Rugarli C
J Immunother; 2008 Jun; 31(5):458-65. PubMed ID: 18463539
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7.
Bourquin C; Schmidt L; Lanz AL; Storch B; Wurzenberger C; Anz D; Sandholzer N; Mocikat R; Berger M; Poeck H; Hartmann G; Hornung V; Endres S
J Immunol; 2009 Nov; 183(10):6078-86. PubMed ID: 19890064
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
16. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets.
Mortier E; Advincula R; Kim L; Chmura S; Barrera J; Reizis B; Malynn BA; Ma A
Immunity; 2009 Nov; 31(5):811-22. PubMed ID: 19913445
[TBL] [Abstract][Full Text] [Related]
17. DC therapy induces long-term NK reactivity to tumors via host DC.
Shimizu K; Fujii S
Eur J Immunol; 2009 Feb; 39(2):457-68. PubMed ID: 19180466
[TBL] [Abstract][Full Text] [Related]
18. Poly I:C-induced activation of NK cells by CD8 alpha+ dendritic cells via the IPS-1 and TRIF-dependent pathways.
Miyake T; Kumagai Y; Kato H; Guo Z; Matsushita K; Satoh T; Kawagoe T; Kumar H; Jang MH; Kawai T; Tani T; Takeuchi O; Akira S
J Immunol; 2009 Aug; 183(4):2522-8. PubMed ID: 19635904
[TBL] [Abstract][Full Text] [Related]
19. Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.
Alici E; Konstantinidis KV; Sutlu T; Aints A; Gahrton G; Ljunggren HG; Dilber MS
Exp Hematol; 2007 Dec; 35(12):1839-46. PubMed ID: 18036444
[TBL] [Abstract][Full Text] [Related]
20. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.
Tomala J; Chmelova H; Mrkvan T; Rihova B; Kovar M
J Immunol; 2009 Oct; 183(8):4904-12. PubMed ID: 19801515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
